98%
921
2 minutes
20
Background: Heart failure (HF) is a primary contributor to morbidity and mortality among patients in intensive care units (ICUs), particularly those experiencing chronic critical illness (CCI). This study aims to develop and validate a machine learning (ML) model for predicting in-hospital mortality in CCI patients with HF.
Methods: Retrospective data from over 200 hospitals were sourced from the Medical Information Mart for Intensive Care III (MIMIC-III), MIMIC-IV, and the eICU Collaborative Research Database (eICU-CRD). Only patients diagnosed with both CCI and HF were included. The MIMIC datasets served as the derivation cohort, while the eICU-CRD dataset was used for external validation. Key predictive variables were identified through recursive feature elimination. A range of ML algorithms, including random forest, K-nearest neighbors, and support vector machine (SVM), were evaluated alongside four other models. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC). Model interpretability was enhanced through SHapley Additive exPlanations (SHAP) and local interpretable model-agnostic explanations.
Results: A total of 780 and 610 patients with CCI and HF were assigned to the derivation and validation cohorts, respectively. Eleven features were selected for model development. The SVM model demonstrated substantial predictive accuracy, with AUROC values of 0.781 and 0.675 in the derivation and validation cohorts. Feature importance analysis using SHAP identified Sequential Organ Failure Assessment score, oxyhemoglobin saturation, and blood pressure as key predictors.
Conclusion: The SVM model developed reliably predicts in-hospital mortality in patients with CCI and HF, offering a valuable tool for early intervention and enhanced patient management.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144373 | PMC |
http://dx.doi.org/10.1177/20552076251347785 | DOI Listing |
Arch Med Res
September 2025
Department and Graduate Institute of Microbiology and Immunology, National Defense Medical Center, Taipei, Taiwan. Electronic address:
Background: Atherosclerosis, a leading cause of cardiovascular disease (CVD) mortality worldwide, is characterized by dysregulated lipid metabolism and unresolved inflammation. Macrophage-derived foam cell formation and apoptosis contribute to plaque formation and vulnerability. Elevated serum galectin-3 (Gal-3) levels are associated with increased CVD risk, and Gal-3 in plaques is strongly associated with macrophages.
View Article and Find Full Text PDFBiomol Biomed
September 2025
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China.
Coronary heart disease (CHD) is a leading cause of morbidity and mortality; patients with type 2 diabetes mellitus (T2DM) are at particularly high risk, highlighting the need for reliable biomarkers for early detection and risk stratification. We investigated whether combining the stress hyperglycemia ratio (SHR) and systemic inflammation response index (SIRI) improves CHD detection in T2DM. In this retrospective cohort of 943 T2DM patients undergoing coronary angiography, associations of SHR and SIRI with CHD were evaluated using multivariable logistic regression and restricted cubic splines; robustness was examined with subgroup and sensitivity analyses.
View Article and Find Full Text PDFMol Pharm
September 2025
Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang 261053, Shandong, P. R. China.
Myocardial injury constitutes a life-threatening complication of sepsis, driven by synergistic oxidative-inflammatory pathology involving dysregulated production of reactive oxygen species (ROS), reactive nitrogen species (RNS), and proinflammatory cytokines. This pathophysiological cascade remarkably elevates morbidity and mortality rates in septic patients, emerging as a key contributor to poor clinical outcomes. Despite its clinical significance, no clinically validated therapeutics currently exist for managing septic cardiomyopathy.
View Article and Find Full Text PDFJ Med Internet Res
September 2025
Faculty of Medicine, The University of Sydney, Sydney, Australia.
Background: Hypertensive disorders of pregnancy (HDP) affect up to 10% of pregnancies and can have adverse short and long-term implications for women and their babies. eHealth interventions include any health service or treatment delivered using the internet and related technology that aims to facilitate, capture, or exchange knowledge. eHealth interventions are increasingly used across many health care settings with improved outcomes.
View Article and Find Full Text PDFAnn Am Thorac Soc
September 2025
Brigham and Women's Hospital, Division of Sleep and Circadian Disorders, Boston, Massachusetts, United States.
Rationale: There are insufficient data to inform the management of central sleep apnea (CSA) in patients with heart failure (HF) with reduced ejection fraction (HFrEF). Nocturnal oxygen therapy (NOT) has been postulated to benefit CSA patients with HFrEF, but has not been rigorously studied. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.
View Article and Find Full Text PDF